Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,776.00
(
-0.08%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.49
(
-1.96%
)
Bitcoin
70,469.11
(
-1.08%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 171397

Tuesday, 12/17/2013 3:52:55 PM

Tuesday, December 17, 2013 3:52:55 PM

Post# of 257262
Re: MNTA-AnaptysBio drug-discovery deal

Presumably a novel drug, and not a biosimilar, as AnaptysBio has a core expertise in the immuno-onc space. Would be interesting to see MNTA pursuing this space given the buzz for PD-1, etc.

The PR uses the phrase novel antibodies, so this collaboration is definitely not about FoB’s. Your guess vis-à-vis immuno-oncology is as good as any, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now